When The Mighty Fall, Smaller Vaccine Players Seize The COVID Day

Agile Decisions Make The Difference

While global vaccine heavyweights such as Merck & Co, Sanofi and GSK have somewhat lagged in the development of vaccines for COVID-19, smaller players have stepped up. This is especially true for highly segmented markets such as China, where agility has been important.

Different types of Covid-19 coronavirus vaccines to protect against disease or pandemic
SMALLER PLAYES SEIZE THE DAY IN COVID VACCINES DEVELOPMENT • Source: Shutterstock

Globally, a number of smaller players have shone in the development of coronavirus vaccines and that has also been the case in China, where the market is highly fragmented and hundreds of makers are vying for a share of the lucrative sector.

This is well illustrated by the case of self-made Chinese entrepreneur Weimin Du, who decided to start his own business and chose vaccines as one of the target sectors

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from COVID-19

More from Scrip